LPA receptor type 1 (LPA1) signaling influences the pathophysiology of many diseases including cancer, obesity, rheumatoid arthritis, as well as lung, liver and kidney fibrosis. The gene discussed is LPAR1; the disease is obesity due to melanocortin 4 receptor deficiency.